174 related articles for article (PubMed ID: 19716573)
21. Mycetoma management and clinical outcomes: the Mycetoma Research Center experience.
Musa EA; Abdoon IH; Bakhiet SM; Osman B; Abdalla SA; Fahal AH
Trans R Soc Trop Med Hyg; 2023 Jan; 117(1):12-21. PubMed ID: 35903002
[TBL] [Abstract][Full Text] [Related]
22. Pathological fractures in mycetoma.
Abd Bagi ME; Fahal AH; Sheik HE; Abdul Wahab O; Taifoor MK; Osmanr EM
Trans R Soc Trop Med Hyg; 2003; 97(5):582-4. PubMed ID: 15307432
[TBL] [Abstract][Full Text] [Related]
23. Mycetoma revisited. Incidence of various radiographic signs.
Abd El-Bagi ME; Fahal AH
Saudi Med J; 2009 Apr; 30(4):529-33. PubMed ID: 19370281
[TBL] [Abstract][Full Text] [Related]
24. Mycetoma of the hand.
Abd El-Bagi ME; Abdul Wahab O; Al-Thagafi MA; El-Sheikh H; Al-Salman K; Taifoor MK; Osman FM
Saudi Med J; 2004 Mar; 25(3):352-4. PubMed ID: 15048175
[TBL] [Abstract][Full Text] [Related]
25. Mycetoma herbal treatment: the Mycetoma Research Centre, Sudan experience.
Ezaldeen EA; Fahal AH; Osman A
PLoS Negl Trop Dis; 2013; 7(8):e2400. PubMed ID: 23991244
[TBL] [Abstract][Full Text] [Related]
26. Mycetoma: a thorn in the flesh.
Fahal AH
Trans R Soc Trop Med Hyg; 2004 Jan; 98(1):3-11. PubMed ID: 14702833
[TBL] [Abstract][Full Text] [Related]
27. Mycetoma spatial geographical distribution in the Eastern Sennar locality, Sennar State, Sudan.
Ganawa ETS; Bushara MA; Musa AEA; Bakhiet SM; Fahal AH
Trans R Soc Trop Med Hyg; 2021 Apr; 115(4):375-382. PubMed ID: 33675358
[TBL] [Abstract][Full Text] [Related]
28. A new model for management of mycetoma in the Sudan.
Fahal A; Mahgoub el S; El Hassan AM; Abdel-Rahman ME; Alshambaty Y; Hashim A; Hago A; Zijlstra EE
PLoS Negl Trop Dis; 2014 Oct; 8(10):e3271. PubMed ID: 25356640
[TBL] [Abstract][Full Text] [Related]
29. [Mycetoma: 130 cases].
Dieng MT; Sy MH; Diop BM; Niang SO; Ndiaye B
Ann Dermatol Venereol; 2003 Jan; 130(1 Pt 1):16-9. PubMed ID: 12605151
[TBL] [Abstract][Full Text] [Related]
30. Characterization of Foot Mycetoma Using Sonography and Color Doppler Imaging.
Gameraddin M; Gareeballah A; Mokhtar S; M Abuzaid M; Alhazmi F; Ali Hamad H
Pak J Biol Sci; 2020 Jan; 23(7):968-972. PubMed ID: 32700845
[TBL] [Abstract][Full Text] [Related]
31. Estimating the burden of mycetoma in Sudan for the period 1991-2018 using a model-based geostatistical approach.
Hassan R; Cano J; Fronterre C; Bakhiet S; Fahal A; Deribe K; Newport M
PLoS Negl Trop Dis; 2022 Oct; 16(10):e0010795. PubMed ID: 36240229
[TBL] [Abstract][Full Text] [Related]
32. Role of socioeconomic factors in developing mycetoma: Results from a household survey in Sennar State, Sudan.
Hounsome N; Hassan R; Bakhiet SM; Deribe K; Bremner S; Fahal AH; Newport MJ
PLoS Negl Trop Dis; 2022 Oct; 16(10):e0010817. PubMed ID: 36251732
[TBL] [Abstract][Full Text] [Related]
33. Human actinomycetoma caused by Actinomadura mexicana in Sudan: the first report.
Siddig EE; Nyuykonge B; Ahmed MT; Hassan R; Saad ESA; Mhmoud NA; Bakhiet SM; van de Sande WWJ; Fahal AH
Trans R Soc Trop Med Hyg; 2021 Apr; 115(4):406-410. PubMed ID: 33382899
[TBL] [Abstract][Full Text] [Related]
34. Eumycetoma and actinomycetoma--an update on causative agents, epidemiology, pathogenesis, diagnostics and therapy.
Nenoff P; van de Sande WW; Fahal AH; Reinel D; Schöfer H
J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):1873-83. PubMed ID: 25726758
[TBL] [Abstract][Full Text] [Related]
35. Eumycetoma by Madurella mycetomatis with 30 years of evolution: therapeutic challenge.
Sampaio FM; Galhardo MC; Quintella LP; Souza PR; Coelho JM; Valle AC
An Bras Dermatol; 2013; 88(6 Suppl 1):82-4. PubMed ID: 24346887
[TBL] [Abstract][Full Text] [Related]
36. Mycetoma in Yemen: clinicoepidemiologic and histopathologic study.
Khatri ML; Al-Halali HM; Fouad Khalid M; Saif SA; Vyas MC
Int J Dermatol; 2002 Sep; 41(9):586-93. PubMed ID: 12358829
[TBL] [Abstract][Full Text] [Related]
37. Treatment of Madura foot: a systematic review.
Salim AO; Mwita CC; Gwer S
JBI Database System Rev Implement Rep; 2018 Jul; 16(7):1519-1536. PubMed ID: 29995713
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of a computational model for mycetoma-causative agents identification.
Omar Ali H; Abraham R; Desoubeaux G; Fahal AH; Tauber C
Trans R Soc Trop Med Hyg; 2024 Apr; 118(4):253-263. PubMed ID: 38088215
[TBL] [Abstract][Full Text] [Related]
39. The Accuracy of Histopathological and Cytopathological Techniques in the Identification of the Mycetoma Causative Agents.
Siddig EE; Mhmoud NA; Bakhiet SM; Abdallah OB; Mekki SO; El Dawi NI; Van de Sande W; Fahal AH
PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007056. PubMed ID: 31465459
[TBL] [Abstract][Full Text] [Related]
40. Management of mycetoma: major challenge in tropical mycoses with limited international recognition.
Ahmed AA; van de Sande WW; Fahal A; Bakker-Woudenberg I; Verbrugh H; van Belkum A
Curr Opin Infect Dis; 2007 Apr; 20(2):146-51. PubMed ID: 17496572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
